Alzheimer’s trial drug shows promise for slowing cognitive decline

A new treatment for early Alzheimer’s disease has shown encouraging results with UCLH (University College London Hospitals) consultant, Prof Cath Mummery, reporting both slower cognitive decline and significant reductions in the tau protein in the brains of participants. Read the summary of UCL (University College London) hospitals here.